The molecular characterization of rare tumors, such as papillary tumors of the pineal region (PTPR), has also been addressed, revealing distinct histopathological and molecular characteristics through DNA methylation profiling of a cohort of 76 cases (ref: Wu doi.org/10.1186/s40478-024-01781-4/). This highlights the importance of molecular diagnostics not only in common neurodegenerative diseases but also in rare tumors, emphasizing the need for comprehensive biomarker studies across various conditions. The integration of these findings underscores the potential for developing targeted diagnostic and therapeutic strategies based on molecular profiles, paving the way for personalized medicine in neurodegeneration.